Conversion from Sandimmune to Neoral in renal transplant: functional histopathological, and pharmacokinetic changes.
Roessler
E
E
Department of Nephrology, Faculty of Medicine, University of Chile, Santiago, Chile.
Herrera
S
S
Espinoza
M
M
Ayala
A
A
Reynolds
E
E
González
F
F
Espinoza
O
O
Undurraga
A
A
Muñoz
R
R
Arcos
O
O
Galaz
G
G
D000935:Antifungal Agents / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004347:Drug Interactions; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D007654:Ketoconazole / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D008657:Metabolic Clearance Rate; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood
D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D012964:Sodium; D003404:Creatinine; D007654:Ketoconazole; D011188:Potassium